HEXO Corp Appoints Trent MacDonald as Acting Chief Financial Officer
October 09 2020 - 4:30PM
HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is
pleased to announce the appointment of Trent MacDonald to its
executive leadership team in the acting role of Chief Financial
Officer, effective today. As previously announced, Mr. MacDonald
joined the Company in September, and his permanent role as Chief
Financial Officer will commence upon the successful completion of
Health Canada’s security clearance process for key personnel, which
has been initiated. Stephen Burwash remained Chief Financial
Officer for a transition period and is stepping down, effective
today.
Mr. MacDonald brings more than 15 years of
financial executive experience to HEXO, working for both publicly
listed and private enterprises. Most recently, he served as the
CFO for Rx Drug Mart, a private pharmacy operator/consolidator,
helping to guide it through significant growth in sales. Prior to
that, he served as Vice President Finance of Indigo (TSX: IDG) and
Vice President Finance for some of Sobeys’ (TSX: EMP.A) largest
divisions and regions. Throughout his career, Mr. MacDonald has
focused extensively on strategic, profitable growth, designing and
implementing processes and solutions to ensure operational
effectiveness and scalability.
In addition to his financial executive
experience, Mr. MacDonald is an award-winning entrepreneur, having
owned and operated successful businesses across several different
industries, from aquaculture and industrial services, to men’s
grooming product retail and barbering. He holds a BBA (Honours,
Accounting and Finance) from St. Francis Xavier University and is a
Chartered Professional Accountant (CPA, CA). He has held accounting
positions at Deloitte and Crowe Soberman.
About HEXO
HEXO Corp is an award-winning consumer packaged
goods cannabis company that creates and distributes innovative
products to serve the global cannabis market. The Company serves
the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis
and Original Stash brands, and the medical market under HEXO
medical cannabis. For more information please visit
hexocorp.com.
Forward Looking Statements
This press release contains forward-looking
information and forward-looking statements within the meaning of
applicable securities laws (“forward-looking statements”).
Forward-looking statements are based on certain expectations and
assumptions and are subject to known and unknown risks and
uncertainties and other factors that could cause actual events,
results, performance and achievements to differ materially from
those anticipated in these forward-looking statements.
Forward-looking statements should not be read as guarantees of
future performance or results. Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak
only as of the date of this press release. The Company disclaims
any intention or obligation, except to the extent required by law,
to update or revise any forward-looking statements as a result of
new information or future events, or for any other reason.
Investor Relations:
invest@HEXO.com www.hexocorp.com
Media Relations: (819) 317-0526
media@hexo.com
HEXO (TSX:HEXO)
Historical Stock Chart
From Aug 2024 to Sep 2024
HEXO (TSX:HEXO)
Historical Stock Chart
From Sep 2023 to Sep 2024